10-K: Ginkgo Bioworks Details Capital Stock Structure and Shareholder Rights in SEC Filing

Sentiment:

Description of Capital Stock


Ginkgo Bioworks outlines the specifics of its multi-class capital stock structure, including voting rights, economic rights, and conversion options, in a recent SEC filing.

Summary

  • Ginkgo Bioworks has authorized 16 billion shares of capital stock, including preferred and three classes of common stock.
  • Class A common stock has one vote per share, Class B has ten votes per share, and Class C generally has no voting rights.
  • Class B stock is primarily for directors and employees, with restrictions on transfer.
  • Holders of common stock vote together as a single class on most matters, with directors elected by a plurality of votes.
  • Stockholder action by written consent is limited, requiring either unanimous director approval or majority Class B ownership.
  • Special meetings can only be called by the board, chairman, CEO, president, or majority Class B holders.
  • All classes of common stock have equal economic rights, including dividends and liquidation proceeds, unless otherwise approved by a majority of each class voting separately.
  • In extraordinary transactions, consideration is distributed ratably per share, unless different treatment is approved by a majority of each class voting separately.
  • Class B stock must be disposed of at a value equal to the prevailing price of Class A stock.
  • Earnout shares, totaling approximately 188.7 million, vest based on Class A stock price targets, with 38.8 million shares already vested.
  • Class B shares can be converted to Class A shares on a one-to-one basis at the holder's option or automatically upon ceasing to be an eligible holder.
  • Certain stockholders have registration rights, allowing them to resell their shares.
  • The board is authorized to issue up to 200 million shares of preferred stock with varying rights and preferences.
  • The charter allows the board to consider the interests of all stakeholders, not just stockholders.
  • Class B holders can elect 25% of the board until their holdings fall below 2% of all common stock.
  • Founders employment can only be terminated for cause with 75% board approval and with the founders consent.
  • The charter and bylaws include anti-takeover provisions, such as a multi-class stock structure and supermajority voting requirements.
  • As of December 31, 2023, there were 51,824,895 outstanding warrants to acquire Class A common stock.
  • Public warrants are exercisable at $11.50 per share and expire five years after the closing date, subject to redemption under certain conditions.
  • The company may redeem warrants for cash at $0.01 per warrant if the stock price exceeds $18.00 for 20 of 30 trading days.
  • The company may require cashless exercise of warrants to reduce dilution.
  • The charter includes an exclusive forum provision, requiring certain legal actions to be brought in Delaware courts.
  • The charter limits director liability and provides for indemnification of officers and directors.
  • The charter renounces corporate opportunities for non-employee directors.
  • The company has opted out of Section 203 of the DGCL, which would have restricted business combinations with interested stockholders.

Sentiment

Score: 7

Explanation: The document is factual and descriptive, outlining the company's capital structure. It does not contain any explicit positive or negative sentiment, but the multi-class structure and anti-takeover provisions could be seen as a mixed bag for investors.

Positives

  • The multi-class structure allows for long-term control by founders and employees.
  • Equal economic rights for all common stock classes ensure fair distribution of profits.
  • The ability to redeem warrants for cash provides a potential source of capital.
  • Cashless exercise of warrants can reduce dilution.
  • The board can consider the interests of all stakeholders, not just stockholders.

Negatives

  • The multi-class structure limits the voting power of Class A stockholders.
  • The anti-takeover provisions may discourage potential acquisitions.
  • The company has opted out of Section 203 of the DGCL, which would have restricted business combinations with interested stockholders.

Risks

  • The multi-class structure concentrates voting power, potentially limiting stockholder influence.
  • Anti-takeover provisions may discourage potential acquisitions.
  • The company has opted out of Section 203 of the DGCL, which would have restricted business combinations with interested stockholders.
  • The company may redeem warrants for cash at a low price, potentially diluting shareholder value.
  • The company may require cashless exercise of warrants, which could reduce the number of shares issued and lessen the dilutive effect of a warrant redemption.

Future Outlook

The document outlines the terms and conditions of the company's capital stock, providing a framework for future operations and potential transactions.

Management Comments

  • Ginkgo may (and expects to) from time to time establish restrictions, policies and procedures relating to transfers and dispositions of shares of Class B common stock as it deems necessary or advisable.
  • Ginkgo may (and expects to) establish from time to time certain restrictions, policies and procedures relating to the general administration of its multi-class stock structure and the conversion of Class B common stock to Class A common stock.

Industry Context

The multi-class stock structure is a common feature in technology and biotech companies, designed to maintain control with founders and early investors. The document provides transparency into the company's governance and capital structure, which is important for investors in the biotech sector.

Comparison to Industry Standards

  • The multi-class stock structure is similar to that of other tech and biotech companies like Google (Alphabet) and Facebook (Meta), which have different classes of stock with varying voting rights.
  • The warrant terms are typical for companies that went public through a SPAC merger, with redemption clauses and cashless exercise options.
  • The exclusive forum provision is also common in Delaware-incorporated companies, aiming to reduce litigation costs and uncertainty.
  • The opting out of Section 203 of the DGCL is a less common but not unheard of decision, which gives the company more flexibility in potential acquisitions.

Stakeholder Impact

  • Shareholders will have varying voting rights based on the class of stock they hold.
  • Employees and directors holding Class B stock will have significant influence over company decisions.
  • Potential acquirers may be discouraged by the anti-takeover provisions.
  • The board is authorized to consider the interests of all stakeholders, not just stockholders.

Next Steps

  • The company may establish further restrictions, policies and procedures relating to transfers and dispositions of shares of Class B common stock.
  • The company may establish further restrictions, policies and procedures relating to the general administration of its multi-class stock structure and the conversion of Class B common stock to Class A common stock.

Key Dates

DateDescription
September 16, 2021Closing Date of the Merger
November 15, 2021First earnout target of $12.50 was met
December 31, 2023Date of financial data

Keywords

capital stock, common stock, preferred stock, voting rights, warrants, shareholder rights, multi-class stock, corporate governance, anti-takeover, redemption, conversion, registration rights, Delaware law, earnouts

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.